Saima Awan's Profile

Thank you for your comment Stacy. I agree, especially as we are seeing more prevalence of certain disease and disorders in pediatric population – such as depression and diabetes. And there is a lack of direction of evidence on how to guide treatment.

Thank you for your comment Liliam, the whole concept behind this innovation is to be more preventative and have early access to appropriate evidence based intervention at the beginning of a chronic disease trajectory. Healthcare costs are most expensive when chronic diseases are poorly managed and lead to multi-morbidities (i.e. poorly managed diabetes could lead to blindness, amputation, kidney failure), requiring more hospitalization in general, and other service utilization down the road. Coming from a Canadian healthcare system, an inpatient hospital stay for one night costs around $3000, which is likely similar in the American system. With a platform that provides better access to evidence for disease management to primary care, along with a continuous improvement cycle of updates based on clinical outcomes from a diverse population using these guidelines, one key outcome will be more appropriate healthcare utilization and cost savings.

Thank you for you comment Suresh. I have developed clinical protocols based on evidence and they are not supposed to replace clinical judgment, instead it is to provide additional information to make an informed decision. Much of medicine is guideline based (developed by physicians and scientists), include decision making tools within disease specific pathways such as Cancer. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037940/
Evidence medicine has existed for a while, my proposal is to enhance it and make it more equitable and accessible through a platform.